This study aimed to evaluate the clinical prognostic implications of postprocedural Thrombolysis in Myocardial Infarction (TIMI) flow in acute myocardial infarction patients. A total of 2796 ST-elevation myocardial infarction (STEMI) and 1720 non ST-elevation myocardial infarction (NSTEMI) patients treated in 8 hospitals affiliated with the Catholic University of Korea and Chonnam National University Hospital were analyzed. The study populations were divided according to the final TIMI flow. The primary outcome were the major adverse cardiac events (MACE), defined as a composite of cardiac deaths (CD), nonfatal myocardial infarctions (MI), and target lesion revascularization (TLR). Over a median follow-up of 3.3 years (minimum 2 to maximum 5 years), MACE and CD occurred more frequently in STEMI patients with TIMI !2 group than those with TIMI 3 (MACE: adjusted hazard ratio [aHR], 1.962; 95% confidence interval [CI] 1.513 to 2.546, P < 0.001, CD: aHR, 3.154, CI 2.308 to 4.309, P < 0.001). However, there was no significant difference between the two subgroups in NSTEMI (aHR, 0.932; 95% CI 0.586 to 1.484, P = 0.087). In STEMI patients, good postprocedural TIMI flow after PCI was associated with favorable clinical outcomes. And the effect of poor TIMI flow in STEMI was on death, not the components of MACE. Meanwhile, postprocedural TIMI flow had no effect on long-term outcomes in NSTEMI patients.
R apid reestablishment of normal (Thrombolysis in Myocardial Infarction [TIMI] grade 3) flow in the infarct-related artery has contributed to the advantages of reperfusion therapies for ST elevation myocardial infarction (STEMI). 1, 2) Currently, percutaneous coronary intervention (PCI) is the first line treatment for patients with STEMI 3, 4) Unfortunately, reopening of a culprit coronary artery after adequate reperfusion therapy does not always improve tissue perfusion. It is called suboptimal coronary flow defined as TIMI flow grade !2. It is well known that suboptimal coronary flow has been associated with poor prognosis in STEMI patients. [4] [5] [6] [7] [8] In detail, it is related to one-month left ventricular dysfunction, increased 1-month or 1-year mortality risk according to post-PCI TIMI flow grade, composite of death, repeat myocardial infarction (MI), target vessel revascularization at 30 days, and increased in-hospital long-term cardiovas-cular mortalities. Meanwhile, it remains unclear whether postprocedural coronary flow after PCI is related with long-term clinical outcomes in non ST-segment elevation myocardial infarction (NSTEMI). Thus, the aim of this multicenter, retrospective, observational study is to evaluate the long-term prognostic role of postprocedural TIMI flow after PCI using a large cohort of acute myocardial infarction.
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Methods Participants: A total of 5025 patients with either STEMI or NSTEMI who had admitted at 9 major cardiovascular centers came under the Convergent Registry of Catholic This large observational registry was designed to evaluate clinical outcomes of patients with acute MI including both STEMI and NSTEMI, and included demographic, clinical, and angiographic data with short-term and long-term clinical outcome data. Of 5025 patients, 509 patients without post-TIMI flow data were excluded and 4516 patients were included in the analyses.
Among 4516 patients, 2796 and 1720 patients were diagnosed with STEMI and NSTEMI, respectively, and underwent successful PCI. STEMI was diagnosed by the presence of chest pain lasting for more than 20 min in association with electrocardiographic changes (ST-segment elevation of !1 mm in at least two extremity electrocardiographic leads or !2 mm in at least contiguous precordial leads, or new-onset left-bundle branch block). NSTEMI was defined as increased cardiac markers with symptoms compatible with myocardial ischemia in the absence of ST-elevation on the index ECG. 9) Meanwhile, in baseline characteristics, smoking included current smokers and ex-smokers and renal failure was defined with diagnosed chronic renal failure, creatinine > 2.0 mg/dL and patients on dialysis. Percutaneous coronary intervention procedure and medical treatment: Coronary angiography and PCI were performed according to current standard guidelines. A definition of successful PCI required the following: 1) Angiographic success: consensus definition prior to the use of stents was the achievement of a minimum stenosis diameter reduction to < 50% in the presence of grade 3 TIMI flow (assessed by angiography). However, with the advent of advanced adjunct technology, including coronary stents, a minimum stenosis diameter reduction to < 20% has been the clinical benchmark of an optimal angiographic result. 2) Procedural success: A successful PCI should achieve angiographic success without in-hospital major clinical complications (e.g., death, MI, emergency coronary artery bypass surgery) during hospitalization. 3) Clinical success: In the short term, a clinically successful PCI includes anatomic and procedural success with relief of signs and/or symptoms of myocardial ischemia after the patient recovers from the procedure. The long-term clinical success requires that the short-term clinical success remains durable and that the patient has persistent relief of signs and symptoms of myocardial ischemia for more than 6 months after the procedure. 10) Antiplatelet therapy and administration of periprocedural anticoagulation were carried out in accordance with standard regimens. All patients were prescribed aspirin (loading dose, 200 mg) plus clopidogrel (loading dose, 300 or 600 mg) before or during PCI. After the procedure, aspirin (100-200 mg/day) was maintained indefinitely. Patients with drug-eluting stents were prescribed clopidogrel (75 mg/ day) for at least 12 months while patients with bare-metal stents were prescribed clopidogrel for at least 1 month. Other cardiac medications were administered at the discretion of treating physicians.
The completeness of restoration of the epicardial blood flow after recanalization of infarct-related artery has been quantified with the Thrombolysis in Myocardial Infarction (TIMI) grading system, which was categorized by each operator. 11) All patients were classified into 2 groups according to the postprocedural TIMI flow which reflects anterograde blood flow of the infarct vessel ( Figure 1) . Study End-Points: The primary end-point was a composite of cardiac death (CD), nonfatal myocardial infarction FIVE YEAR FOLLOW-UP RESULTS IN THE COREA-AMI REGISTRY (MI), and target lesion revascularization (TLR). CD was defined as any death due to a proximate cardiac cause such as MI, low-output failure, arrhythmia, and unwitnessed death. MI was defined as newly developed Q wave, raised CK-MB, Tn-I or T above the normal ranges, typical ischemic symptom with accompanied ST-segment changes in 2 or more contiguous leads on the 12-lead ECG.
Immediate postprocedural and in-hospital events were recorded. After the discharge, the patients were followed up in the out-patient clinics or by telephone 1, 6, and 12 months after the procedure and then annually. Information on censored survival data and death was obtained from hospital records or through telephone calls to relatives of the patients. All clinical outcomes of interest were confirmed by source documents and were centrally adjudicated by a local events committee at the Cardiovascular Center of Seoul St. Mary's Hospital by an independent group of clinicians unaware of patient status.
Information about death was validated by records from the National Population Registry of the Korea National Statistical Office using a unique personal identification number for each patient. The study protocol was approved by the institutional review board of each participating institution, and was conducted according to the Declaration of Helsinki. Each patient was provided with written informed consent. Statistical analyses: Student t-test and χ 2 test (or the Fisher exact test) were used to compare the means and proportion of baseline clinical and angiographic characteristics between 2 groups. Continuous variables were expressed as the mean ± standard deviation and categorical variables were expressed as a number (percentage). Cox proportional hazard model was used to estimate the hazard ratio (HR) and 95% confidence interval (CI) for the statistical impact of good postprocedural TIMI flow after PCI on the clinical events.
The incidence of each adverse event was estimated at 12, 24, 48, and 60 months, displayed with Kaplan-Meier curves and compared with the log-rank test.
Propensity score (PS) matching was used to identify a cohort of patients with similar baseline characteristics and to address bias and confounds in this observational study. Propensity score was computed by nonparsimonious multiple logistic regression analysis (cstatistics = 0.637 in STEMI groups, 0.707 in NSTEMI groups). All baseline characteristics described in Table I were matched by the variables that showed differences in the overall population. Matching was performed with the use of a 1:1 nearest neighbor matching, from initial 7 to 1 digit. We confirmed the model reliability with goodnessof-fit test (0.437 in STEMI group, 0.301 in NSTEMI group).
In the matched cohort, paired comparisons were performed with the use of McNemar's test for binary variables and a paired Student's t-test for continuous variables. In the PS matching population, an elevation in the risk of outcomes was compared using a conditional Cox regression model.
Meanwhile, multivariable logistic regression analyses were carried out to identify independent predictors associ-ated with poor postinterventional TIMI flow after PCI. All of the variables in Table I were included and analyzed to perform univariable logistic regression analysis. On the basis of the variables that were significant (P < 0.05) according to univariable logistic regression analysis, a multivariable logistic regression model was constructed.
A two-tailed P-value of < 0.05 was considered statistically significant. All statistical analyses were performed using a Statistical Analysis Software (SAS, version 9.2, SAS Institute, Cary, NC, USA).
Results
Baseline Characteristics of the overall study population: Baseline and angiographic characteristics are presented according to the existence of ST elevation (Table  I) . A total of 4516 patients included 2785 patients with STEMI and 1720 patients with NSTEMI. Their mean age was 62.6 years. In the patient group of TIMI flow grade 3 in the overall population, 71.5% were men, 31.2% had diabetes, and 49.8% had history of hypertension. In the patient group of TIMI flow grade !2, 70.3% were men, 34% had diabetes, and 52.6% had hypertension. Their mean age was 63.6 years. There were no significant statistical differences between the two groups. The patient group of TIMI flow !2 were lighter smokers and included more Killip class IV and more extensive coronary artery disease (CAD). Their left ventricular ejection fraction (LVEF) on admission was lower, and total cholesterol and high density lipoprotein (HDL) cholesterol were also lower, whereas low density lipoprotein (LDL) cholesterol and baseline high-sensitivity C-reactive protein (hsCRP) were higher. In addition, in the patient group of TIMI flow !2, the left anterior descending artery (LAD) was the most frequent culprit artery (51.7%), followed by right coronary artery (RCA, 31.4%) and left circumflex artery (LCX, 11%), and the same incidence pattern was shown in the patient group of TIMI flow 3 (LAD, RCA, LCX -47.9%, 33.8%, 16.2%). These results were consistent in the comparison analysis of the patients with STEMI and NSTEMI. In both STEMI and NSTEMI groups, the incidence of Killip IV was higher and the patients tended to be lighter smokers and had lower total cholesterol when TIMI flow was !2. The incidence pattern of culprit vessel was also comparable to that of the overall population. However, NSTEMI patients with TIMI flow !2 had more extensive CAD, lower fasting blood glucose, and lower LDL cholesterol, whereas STEMI patients with TIMI flow !2 had lower LVEF, lower HDL cholesterol, and higher hsCRP.
Baseline Characteristics of the PS-Matched population:
After PS matching, 344 patients (overall population), 115 patients (STEMI), and 299 patients (NSTEMI) were allocated into each group (Table II) . In the matched cohort, there were no significant differences in baseline characteristics. Clinical outcomes of the overall population: The median follow-up duration was 5 years. Among the patients with STEMI, the cumulative rates of primary end-point including CD, MI, and TLR were significantly higher in the suboptimal postcoronary flow group (TIMI !2) than Kim, ET AL Table III ).
Kaplan-Meier and landmark analysis in the PSmatched population:
The Kaplan-Meier curve indicated a significantly higher risk for primary end-point in the STEMI patients with TIMI flow ! 2 during 5 years (event-free survival rate: 66.9% versus 80.4%, P < 0.001, Figure 2 ). The 3-month landmark analysis revealed that there was no significantly higher risk for the primary endpoint in the STEMI patients with TIMI flow !2 after 3 months (P = 0.846, Figure 4 ). Figure 2 & 3 showed Kaplan-Meier curves for the incidence of MACE and CD in both STEMI and NSTEMI patients during 5 years. Although the CD-free survival rate for 5 years was significantly lower in the STEMI patients with TIMI flow !2 (74.5% versus 90.4%; P < 0.001), the 5-year landmark Kim, ET AL analysis did not demonstrate a significant difference in CD beyond 3 months in STEMI patients (P = 0.267, Figure 4 ). However, MI or TLR-free survival rates had no significant differences during the 5-year follow-up (P = 0.906, P = 0.705, respectively). On the other hand, the risk for primary end-point in the NSTEMI patients was not significantly different in both groups during the 5-year follow-up (78.6% versus 82.1%; P = 0.087) Predictors of the postprocedural suboptimal coronary flow in MI: Univariable and multivariable logistic regression analyses were performed to identify independent predictors of postinterventional suboptimal coronary flow in STEMI and NSTEMI after PCI. In the multivariable logistic regression model, culprit vessel (LCX, LM disease), and multivessel disease in NSTEMI and LVEF, HDL cholesterol, and Hb in STEMI were independent predictors of the postprocedural suboptimal coronary flow (Table IV) . Compared with the culprit LAD lesion, the prevalence of postprocedural suboptimal flow was not significantly higher in culprit RCA lesion (adjusted HR = 1.063, P = 0.602) but higher in culprit LM lesion (adjusted HR = 3.182, P = 0.001) in NSTEMI patients. Furthermore, the prevalence of postprocedural suboptimal flow was higher if CAD was extensive in NSTEMI (adjusted HR = 2.031, P = 0.002). Unexpectedly, the prevalence of postprocedural suboptimal flow was lower in the culprit LCX lesion than the LAD lesion (adjusted HR = 0.544, P = 0.001) in NSTEMI patients. Multivariable logistic regression revealed that LVEF and HDL cholesterol are the predictors for the lower prevalence of postprocedural suboptimal flow (adjusted HR = 0.980, P = 0.002; adjusted HR = 0.984, P = 0.025) and Hb is the predictor for the higher prevalence of postprocedural suboptimal flow (adjusted HR = 1.081, P = 0.026) in STEMI patients.
Discussion
This large, multicenter cohort analysis evaluated the outcomes of STEMI and NSTEMI patients during 5 years according to postprocedural TIMI flow. This study included a relatively large number of patients with STEMI and NSTEMI who had undergone primary PCI. The subjects were followed up for 5 years and the results found that suboptimal coronary flow after primary PCI was associated with an increased risk for long-term mortality in STEMI. The mortality risk was high during the first 3 months but became insignificant beyond this time point. Meanwhile, there was no significant difference in the NSTEMI patients with suboptimal coronary flow over the 5 years.
Despite the development of the PCI technique, devices, and medications over the past decades, the incidence of suboptimal flow after primary PCI remains relatively high. This considerable final TIMI flow ! 2 is thought to be due to microvascular dysfunction resulting from vascular constriction, distal microembolization, endothelial dysfunction secondary to endothelial injury, capillary plugging by platelets, neutrophils, and erythrocytes, and intracellular and interstitial edema. 12) We observed suboptimal coronary flow after primary PCI in 8.2% and 6.7% of patients with STEMI and NSTEMI, respectively. This study also identified an association between the final coronary flow and mortality during 5 years after PCI in STEMI and NSTEMI, respectively. The present analysis demonstrated that mortality was significantly lower in the patients with TIMI grade 3 after PCI (19.6%), as compared with those with TIMI !2 (33.1%) over 5 years in STEMI patients, whereas mortality did not significantly differ (21.4% versus 17.9%) in NSTEMI patients. As is well known, complete early reperfusion (TIMI grade 3) of the infarct-related artery in STEMI is related with mortality benefit. 2, 4, 13, 14) It is consistent that our study showed early survival benefit, but the effect did not persist beyond the early phase of postintervention. This finding underscores the importance of preventing the development of TIMI !2 flow as the optimal strategy to improve clinical outcomes and decrease resource utilization in patients carrying out primary PCI since the outcomes are relatively dismal once no-reflow occurs.
Above this, we found that the effect of poor TIMI flow in STEMI is uniquely on death and not the other components of MACE (Table III, Figures 2, 3) . Meanwhile, preTIMI flow of angiography in NSTEMI remains controversial. Although some previous papers contended that preprocedural TIMI flow was an independent predictor for survival in NSTEMI patients, [15] [16] [17] others reported that preTIMI flow in NSTEMI did not ap-pear to affect survival or mortality. 7, 18, 19) In this regard, our study has an important implication. We focused on post-epicardial flow after PCI, irrespective of preTIMI flow and it indicated that postprocedural coronary flow showed no significant impact on Kim, ET AL long-term mortality as well as short term prognosis in NSTEMI patients. This result is supported by recent reports that early intervention made no difference in preventing primary outcome as compared with delayed approach. [20] [21] [22] Although our study was not differentiated in accordance with risk stratification in NSTEMI, it suggests that not only appropriate intervention time but also the presence of complete final coronary flow through any de-vice procedure or medial approach might affect less than expected in NSTEMI patients.
These differences may be explained by pathophysiologic differences between NSTEMI and STEMI. Differences in the culprit lesion of the two states have recently been demonstrated by optical coherence tomography. The incidences of plaque rupture (70% versus 47%), thin-cap fibroatheroma (78% versus 49%), and red thrombus (78% versus 49%) were significantly higher in STEMI, compared to NSTEMI patients, and they had a larger ruptured cavity area than NSTEMI patients. 23) Therefore, as damages by infarct transmurality are not relatively serious in NSTEMI compared to STEMI, postinterventional coronary flow could have less influences on overall survival benefit. And, there is a potential for early hazard due to intervention on unstable plaques with fresh thrombus. [24] [25] [26] Kim, ET AL Conversely, a relative delayed strategy in NSTEMI might offer benefits through plaque passivation by optical medical treatment followed by intervention on more stable plaques. 27, 28) Also, the role of ischemic preconditioning could offer substantial protection in NSTEMI patients. Subendocardial viability in NSTEMI patients is thought to be less dependent on collateral circulation and thus more likely to be protected by preconditioning. 29) Preconditioning does not prevent or preclude the development of myocardial necrosis, but rather protects the heart by slowing or delaying myocyte death. 30, 31) In addition, several heterogeneous characteristics of NSTEMI might have an influence on clinical outcome in our study. Angiographically, NSTEMI patients in our study included occluded culprit arteries defined as preTIMI 0 or 1. Although these patients, often termed "STEMI equivalents", 17, 32) have no ST elevation change in ECG analysis, it has been shown to have worse clinical outcomes compared to NSTEMI patients. 16, 17) Procedurally, our study underwent emergent, urgent, and delayed PCI except for medial approach in NSTEMI patients. Accordingly, it could affect the clinical outcome in NSTEMI patients. Above these, various medical approaches might be associated with the mortality in NSTEMI patients. Commonly, NSTEMI patients could add anticoagulant therapy (unfractionated heparin, enoxaparin, bivalirudin, or fondaparinus) to antiplatelet therapy for initial management. In our study, although we used various anticoagulant medications in conjunction with standard guideline management, we did not always use anticoagulant therapy for NSTEMI management.
One of the most important findings in this study is the identification of the certain independent predictors for poor angiographic coronary flow after PCI. Previous studies identified DM, age, hypertension, and pre-PCI TIMI flow as the independent predictors for suboptimal coronary flow. [33] [34] [35] In this study, postprocedural suboptimal coronary flow was diagnosed by coronary angiography and we found that LVEF, HDL cholesterol, Hb in STEMI and culprit vessel type, and the extent of multivessel disease in NSTEMI were the independent predictors for postprocedural suboptimal coronary flow after PCI.
Hb was independently associated with postintervention TIMI grade !2 flow in STEMI patients. It is important to notice that a high Hb value, a major determinant of whole blood viscosity, predicts cardiovascular events. 36) The relationships between blood viscosity, erythrocyte deformability, coronary risk, and endothelial function modify blood fluidity. A reduced fluidity may limit the microcirculatory flow due to the viscus resistance. 37) Coronary anatomy and myocardial blood flow are the major determinants of clinical symptoms and survival in patients with epicardial coronary artery. 37, 38) LVEF and HDL were found to be relatively benign predictors for postprocedural suboptimal flow despite the presence of other factors in STEMI patients. Although previous studies found a significant relationship between preprocedural TIMI flow and enzymatic infarct size and predischarge EF, 18, 39) this study showed that postprocedural TIMI flow related with predischarge LVEF. It could be related to more extensive myocardial salvage, and thus better EF and more limited infarct size. Meanwhile, in case of HDL cholesterol, it could affect atherosclerosis which has been identified as an inflammatory process 40) driven by the adaptive (T and B cells) immune system and dendritic cells. 41) In our study, a rise of HDL cholesterol might be favorably associated with early inflammatory process for establishment of good coronary flow in STEMI patients. In addition, this study showed that the final coronary flow after PCI was better in LCX territory than in other treated arteries in NSTEMI (HR 0.544 [0.304-0.975], P = 0.001), even after the adjustment for the presence of other factors. In contrast, patients with the left main (LM) disease tended to have the poor final coronary flow (HR 3.182 [1.444-7.012], P = 0.001) more often as seen in LAD lesion (Table IV) . Also, even though other culprit vessels did not cause significant differences in mortality risk for 5 years, there were no deaths in postprocedural suboptimal flow group of LCX lesion in NSTEMI patients ( Supplemental Table) . Large and prospective trials will be necessary to more definitely settle this issue.
There are several potential limitations to our study. First, it was a nonrandomized study, and results are prone to be influenced by selection bias and confounding factors. To control this matter, PS matching was performed but the effects of hidden bias affected by the unmeasured confounders were not completely excluded. Second, it is also possible that the rates of suboptimal coronary flow after primary PCI may have been under-reported because TIMI grades were classified by each operator. Myocardial perfusion grade or myocardial blush would have provided further diagnostic information. Third, the limited number of individuals in postprocedural suboptimal coronary flow groups of the patients with STEMI and NSTEMI may have affected the outcomes of this study, although appropriate statistical adjustments were attempted. Finally, this trial has an intrinsic limitation itself due to several heterogenic components in the groups in terms of angiographical, procedural, and medical aspects.
Conclusion
This long-term trial was conducted to evaluate the differences in long-term prognosis between two MI groups according to post-TIMI flow. The development of suboptimal coronary flow in patients with STEMI after primary PCI was associated with an increased risk for long-term mortality. And we need to take notice that poor postcoronary TIMI flow is uniquely associated with cardiac death, not the other components of MACE. Meanwhile, post-TIMI flow in patients with NSTEMI did not have any long-term effects on survival. Our results suggest that cautious assessment for early risk stratification should be taken into consideration according to initial MI patients' characteristics and may provide guidance in future trials for timing and aggressiveness of revascularization in ACS.
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